MichaelAndyPfallerMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Pfaller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1979 - 1983
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1976 - 1977
Washington University in St. Louis School of MedicineClass of 1976

PubMed

14 citations
Surveillance of omadacycline activity tested against clinical isolates from the United States: Report from the SENTRY Antimicrobial Surveillance Program, 2019: Omadacy...
Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm
Journal of Global Antimicrobial Resistance. 2021-11-11
10 citations
Ceftolozane-Tazobactam Activity Against Clinical Isolates of Pseudomonas aeruginosa from ICU Patients with Pneumonia: United States, 2015-2018.
Michael A. Pfaller, Dee Shortridge, Kelly A Harris, Mark W Garrison, C Andrew DeRyke
International Journal of Infectious Diseases. 2021-09-28
10 citations
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years
Michael A. Pfaller, Cecilia G Carvalhaes, Shawn A. Messer, Paul R. Rhomberg, Mariana Castanheira
Diagnostic Microbiology and Infectious Disease. 2021-07-01

Other

Antifungal susceptibility testing
Pfaller MA
http://www.uptodate.com/contents/antifungal-susceptibility-testing
UpToDate, Wolters Kluwer Health - 2012-09-10